Integrated budget impact model to estimate the impact of introducing selpercatinib as a tumor-agnostic treatment option for patients with RET -altered solid tumors in the US.

Autor: Bhandari NR; Eli Lilly and Company, Indianapolis, IN, USA., Gilligan AM; Eli Lilly and Company, Indianapolis, IN, USA., Myers J; Medical Decision Modeling Inc, Indianapolis, IN, USA., Ale-Ali A; Eli Lilly and Company, Indianapolis, IN, USA., Smolen L; Medical Decision Modeling Inc, Indianapolis, IN, USA.

Publikováno v: Journal of medical economics [J Med Econ] 2024 Jan-Dec; Vol. 27 (1), pp. 348-358. Date of Electronic Publication: 2024 Mar 06.

Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma.

Autor: Jagannath S; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Joseph N; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Crivera C; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Kharat A; Janssen Scientific Affairs, LLC, Horsham, PA, USA. AKharat2@its.jnj.com., Jackson CC; Janssen R&D, Raritan, NJ, USA., Valluri S; Janssen Global Services, LLC, Raritan, NJ, USA., Cost P; Janssen Global Services, LLC, Raritan, NJ, USA., Phelps H; Janssen Global Services, LLC, Raritan, NJ, USA., Slowik R; Janssen Global Services, LLC, Raritan, NJ, USA., Klein T; Medical Decision Modeling Inc., Indianapolis, IN, USA., Smolen L; Medical Decision Modeling Inc., Indianapolis, IN, USA., Yu X; Medical Decision Modeling Inc., Indianapolis, IN, USA., Cohen AD; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.

Publikováno v: Oncology and therapy [Oncol Ther] 2023 Jun; Vol. 11 (2), pp. 263-275. Date of Electronic Publication: 2023 Apr 04.

EE263 Impact of Treatment Duration on the Potential Cost-Effectiveness of Disease-Modifying Therapies for the Treatment of Early Symptomatic Alzheimer's Disease

Autor: Boustani, M, Garrison, LP, Smolen, L, Belger, M, Klein, TM, Murphy, DR, Burge, RT, Johnston, J

Publikováno v: In Value in Health July 2022 25(7) Supplement:S385-S385

EPH120 Comparing the Effectiveness and Cost-Effectiveness of SARS-COV-2 Screening Strategies Using Rapid Antigen Tests in a Residential College Campus

Autor: Smolen, H, Johnston, A, Smolen, L, Yih, Y

Publikováno v: In Value in Health July 2022 25(7) Supplement:S456-S457

PIT7 Pharmacoeconomic Benefits of over-the-Counter Topical Diclofenac in the Treatment of Mild-to-Moderate ACUTE PAIN or Injury and Short-TERM PAIN Associated with Chronic Conditions in Germany

Autor: Asukai, Y., Deutsch, D., Klein, T., Smolen, L., Rios Martinez, S.

Publikováno v: In Value in Health December 2020 23 Supplement 2:S575-S575